Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 52, 2017 - Issue 9
Submit an article Journal homepage
492
Views
11
CrossRef citations to date
0
Altmetric
Original Article

Epidemiology and causes of death in a Swedish cohort of patients with autoimmune hepatitis

Åsa Danielsson BorssénDepartment of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden; Correspondence[email protected]
View further author information
,
Hanns-Ulrich MarschallDepartment of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden; View further author information
,
Annika BergquistDepartment of Medicine, Section of Hepatology and Gastroenterology, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden; View further author information
,
Fredrik RorsmanDepartment of Medical Sciences, Section of Gastroenterology and Hepatology, Uppsala University, Uppsala, Sweden; View further author information
,
Ola WeilandDepartment of Medicine, Division of Infectious Diseases, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden; View further author information
,
Stergios KechagiasDepartment of Gastroenterology and Hepatology, University Hospital, Linköping, Sweden; ;Department of Medical and Health Sciences, Linköping University, Linköping, Sweden; ORCID Iconhttp://orcid.org/0000-0001-7614-739XView further author information
ORCID Icon,
Nils NyhlinDepartment of Gastroenterology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden; View further author information
,
Hans VerbaanDepartment of Clinical Sciences, Gastroenterology Division, Lund University, University Hospital Skane, Malmö, Sweden; View further author information
,
Emma NilssonDepartment of Clinical Sciences, Gastroenterology Division, Lund University, University Hospital Skane, Lund, SwedenView further author information
&
Mårten WernerDepartment of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden; View further author information
 show all
Pages 1022-1028 | Received 01 Apr 2017, Accepted 23 May 2017, Published online: 31 May 2017

References

  • Ngu JH, Bechly K, Chapman BA, et al. Population-based epidemiology study of autoimmune hepatitis: a disease of older women?. J Gastroenterol Hepatol.. 2010;25:1681–1686.
  • Amarapurkar DN, Patel ND. Spectrum of autoimmune liver diseases in western India. J Gastroenterol Hepatol. 2007;22:2112–2117.
  • Hurlburt KJ, McMahon BJ, Deubner H, et al. Prevalence of autoimmune liver disease in Alaska Natives. Am J Gastroenterol. 2002;97:2402–2407.
  • Werner M, Prytz H, Ohlsson B, et al. Epidemiology and the initial presentation of autoimmune hepatitis in Sweden: a nationwide study. Scand J Gastroenterol. 2008;43:1232–1240.
  • Boberg KM, Aadland E, Jahnsen J, et al. Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population. Scand J Gastroenterol. 1998;33:99–103.
  • Gronbaek L, Vilstrup H, Jepsen P. Autoimmune hepatitis in Denmark: incidence, prevalence, prognosis, and causes of death. A nationwide registry-based cohort study. J Hepatol. 2014;60:612–617.
  • Soloway RD, Summerskill WH, Baggenstoss AH, et al. Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis. Gastroenterology. 1972;63:820–833.
  • Murray-Lyon IM, Stern RB, Williams R. Controlled trial of prednisone and azathioprine in active chronic hepatitis. Lancet. 1973;1:735–737.
  • Cook GC, Mulligan R, Sherlock S. Controlled prospective trial of corticosteroid therapy in active chronic hepatitis. Q J Med. 1971;40:159–185.
  • Werner M, Wallerstedt S, Lindgren S, et al. Characteristics and long-term outcome of patients with autoimmune hepatitis related to the initial treatment response. Scand J Gastroenterol. 2010;45:457–467.
  • Roberts SK, Therneau TM, Czaja AJ. Prognosis of histological cirrhosis in type 1 autoimmune hepatitis. Gastroenterology 1996;110:848–857.
  • Feld JJ, Dinh H, Arenovich T, et al. Autoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcome. Hepatology. 2005;42:53–62.
  • Delgado JS, Vodonos A, Malnick S, et al. Autoimmune hepatitis in southern Israel: a 15-year multicenter study. J Dig Dis. 2013;14:611–618.
  • Hoeroldt B, McFarlane E, Dube A, et al. Long-term outcomes of patients with autoimmune hepatitis managed at a nontransplant center. Gastroenterology. 2011;140:1980–1989.
  • Alvarez F, Berg PA, Bianchi FB, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 1999;31:929–938.
  • Duberg A, Janzon R, Back E, et al. The epidemiology of hepatitis C virus infection in Sweden. Euro Surveill. 2008;13.
  • Dödsorsaksstatistik Historik, produktionsmetoder och tillförlitlighet [Internet]. Welfare TNBoHa, editor. The National Board of Health and Welfare; 2010 [cited 2016 Dec 11]. p. 38. Available from: http://www.socialstyrelsen.se
  • Causes of Death 2010. The National Board of Health and Welfare; [Internet]. 2011 [cited 2016 Dec 11]. Available from: http://www.socialstyrelsen.se
  • Befolkning (Population). Statistics Sweden; [Internet]. 2011 [cited 2016 Dec 27]. Available from: http://www.scb.se/statistik/_publikationer/ov0904_2011a01_br_05_a01br1101.pdf
  • van Gerven NM, Verwer BJ, Witte BI, et al. Epidemiology and clinical characteristics of autoimmune hepatitis in the Netherlands. Scand J Gastroenterol. 2014;49:1245–1254.
  • Al-Chalabi T, Underhill JA, Portmann BC, et al. Impact of gender on the long-term outcome and survival of patients with autoimmune hepatitis. J Hepatol. 2008;48:140–147.
  • Ngu JH, Gearry RB, Frampton CM, et al. Predictors of poor outcome in patients with autoimmune hepatitis: a population-based study. Hepatology. 2013;57:2399–2406.
  • Czaja AJ, Donaldson PT. Gender effects and synergisms with histocompatibility leukocyte antigens in type 1 autoimmune hepatitis. Am J Gastroenterol. 2002;97:2051–2057.
  • Floreani A, Niro G, Rosa Rizzotto E, et al. Type I autoimmune hepatitis: clinical course and outcome in an Italian multicentre study. Aliment Pharmacol Ther. 2006;24:1051–1057.
  • Kanzler S, Lohr H, Gerken G, et al. Long-term management and prognosis of autoimmune hepatitis (AIH): a single center experience. Z Gastroenterol. 2001;39:339–341, 44–48.
  • Yoshizawa K, Matsumoto A, Ichijo T, et al. Long-term outcome of Japanese patients with type 1 autoimmune hepatitis. Hepatology. 2012;56:668–676.
  • Montano-Loza AJ, Carpenter HA, Czaja AJ. Consequences of treatment withdrawal in type 1 autoimmune hepatitis. Liver Int. 2007;27:507–515.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.